R. Hildebrandt et al., PHARMACOKINETICS OF FENOTEROL IN PREGNANT AND NONPREGNANT WOMEN, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 275-277
The pharmacokinetics of the beta2-adrenergic drug fenoterol, which is
used as a tocolytic agent in pregnancy, has been investigated in pregn
ant (n = 9) and nonpregnant (n = 5) women during a constant rate intra
venous infusion. Clearance and mean residence time were found to be 19
90 (1879/2220; Median, Q25/Q75) ml/min and 9.2 (8.0/14.0) min in the p
regnant and 2126 (1915/2130) ml/min and 16.6 (16.5/32.1) min in the no
npregnant women, respectively. In addition, fenoterol clearance was es
timated in 88 women from a single blood sample collected at steady sta
te during IV therapy and the effect of gestational age on clearance wa
s studied. Clearance displayed large interindividual variation. There
was no apparent correlation between clearance and gestational age. We
conclude that there is no need to adjust the dose on pharmacokinetic g
rounds in the course of pregnancy.